Influence of hypolipidemic drugs on lipid metabolism in patients with coronary heart disease in combination with obesity

Abstract

In the study, patients were prescribed a lipid-lowering diet and the corresponding hypolipemic drugs (atorvastatin 20 mg; rosuvastatin 20 mg and fenofibrate 145 mg). The study was carried out for three months. During the study, most patients managed to achieve the target levels of lipid metabolism. With the help of dietary nutrition, it is possible to reduce the level of total cholesterol by 0.5-1.5 mmol / l. This usually occurs within 3 months, but even in the absence of a positive effect, the diet should be followed for at least 6 months before deciding whether to prescribe lipid-lowering drugs